DEPTOR, an endogenous inhibitor of mTORC1 activity, is dramatically suppressed in VHL-deficient ccRCC cell lines as well as ccRCC patient samples, suggesting one mechanism for increasing mTORC1 activity during ccRCC progression. This evidence concerns the gene VHL and nonpapillary renal cell carcinoma.